Fox Chase Cancer Center’s Radiation Oncology Department Earns Accreditation from the American College of Radiology

February 23, 2015

PHILADELPHIA (February 23, 2015)—Fox Chase Cancer Center’s Radiation Oncology Department, an international leader known for offering the latest advancements in radiation treatment, has earned accreditation from the American College of Radiology (ACR) for another three years at both its main campus in Northeast Philadelphia and Buckingham facility.

The ACR is the nation’s oldest and most widely accepted radiation oncology accrediting body –with over 600 accredited sites, and 27 years of accreditation experience. Its seal of accreditation represents the highest level of quality and patient safety for the delivery of radiation therapy.

“The ACR accreditation is a high honor in the oncology world, and we have much to be proud of as it demonstrates that Fox Chase meets, and often exceeds, nationally accepted standards of care,” says Richard I. Fisher, President and CEO of Fox Chase Cancer Center.  “This reaffirmation of confidence is testimony to the compassionate, skillful services – underpinned by high-level science and deep empathy – that we provide our patients.”

In its findings, the ACR acknowledged the radiation physics team at Fox Chase as having “long been an asset to the medical physics community for publishing and introducing new technology and techniques,” noting that this was evident in the survey.

The accreditation is awarded only to facilities meeting specific Practice Guidelines and Technical Standards developed by ACR after a peer-review evaluation by board-certified radiation oncologists and medical physicists who are experts in the field. Patient care and treatment, patient safety, personnel qualifications, adequacy of facility equipment, quality control procedures, and quality assurance programs are assessed. The findings are reported to the ACR Committee on Radiation Oncology Accreditation, which subsequently provides the practice with a comprehensive report they can use for continuous practice improvement. 

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.


For more information, call 888-369-2427

Connect with Fox Chase